A systematic review of the role of vitamin D and calcium in premenstrual syndrome

다국어 초록 (Multilingual Abstract)

Premenstrual syndrome (PMS) is a common disorder that affects millions of women of reproductive age worldwide.
In recent years, there has been a focus on finding accessible, acceptable, and cost-effective therapeutic approacheswith minimal side effects to treat the symptoms of PMS. This systematic review aimed to investigate the role ofcalcium and vitamin D in Premenstrual syndrome. The PubMed, EMBASE, Web of Science, Scopus, Science Direct, andGoogle Scholar databases were systematically searched for relevant articles from clinical trial, case-control, and crosssectionalstudies. The Strengthening the Reporting of Observational Studies in Epidemiology checklist was used toassess the quality of the selected papers. A total of 28 eligible high-quality papers were reviewed. Low serum levelsof calcium and vitamin D during the luteal phase of the menstrual cycle were found to cause or exacerbate thesymptoms of PMS. Therefore, the administration of calcium and vitamin D supplements or the use of a diet rich inthese two substances can restore serum levels and eliminate or reduce the symptoms of PMS. Calcium and vitamin Dsupplementation are recommended as an inexpensive, low-risk, acceptable, and accessible approach to eliminate orreduce the symptoms of PMS.

참고문헌 (Reference)

1 Eyles DW, "Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease" 34 : 47-64, 2013

2 Tartagni M, "Vitamin D supplementation for premenstrual syndrome-related mood disorders in adolescents with severe hypovitaminosis D" 29 : 357-361, 2016

3 Mun MJ, "Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers : a meta-analysis" 81 : 256-265, 2015

4 Vaidya A, "Vitamin D and vascular disease : the current and future status of vitamin D therapy in hypertension and kidney disease" 14 : 111-119, 2012

5 Bertone-Johnson ER, "Vitamin D and the occurrence of depression : causal association or circumstantial evidence" 67 : 481-492, 2009

6 이아름, "Vitamin D Proliferates Vaginal Epithelium through RhoA Expression in Postmenopausal Atrophic Vagina tissue" 한국분자세포생물학회 40 (40): 677-684, 2017

7 Holick MF, "Vitamin D : a D-Lightful health perspective" 66 : S182-94, 2008

8 Sen AP, "Use of magnesium in traumatic brain injury" 7 : 91-99, 2010

9 Karimi Z, "Treatment of premenstrual syndrome : appraising the effectiveness of cognitive behavioral therapy in addition to calcium supplement plus vitamin D" 7 : 41-50, 2018

10 Freeman EW, "Therapeutic management of premenstrual syndrome" 11 : 2879-2889, 2010

11 Skowrońska P, "The role of vitamin D in reproductive dysfunction in women-a systematic review" 23 : 671-676, 2016

12 Sepehrirad M, "The role of complementary medicine in control of premenstrual syndrome evidence based(Regular Review Study)" 19 : 11-22, 2016

13 Rajaei S, "The relationship between serum vitamin D level and premenstrual syndrome in Iranian women" 14 : 665-668, 2016

14 Bendich A, "The potential for dietary supplements to reduce premenstrual syndrome(PMS)symptoms" 19 : 3-12, 2000

15 Taghizadeh Z, "The effect of cognitive behavioural psycho-education on premenstrual syndrome and related symptoms" 20 : 705-713, 2013

16 Abdnezhad R, "The effect of Salvia(Sage)extract on the emotional symptoms of premenstrual syndrome" 20 : 84-94, 2017

17 Saeedian Kia A, "The association between the risk of premenstrual syndrome and vitamin D, calcium, and magnesium status among university students : a case control study" 5 : 225-230, 2015

18 Abbasi ST, "Serum magnesium and 25-hydroxy cholecalciferol in premenstrual syndrome during luteal phase" 16 : 209-212, 2017

19 Halbreich U, "Selective serotonin reuptake inhibitors and initial oral contraceptives for the treatment of PMDD : effective but not enough" 13 : 566-572, 2008

20 Faghih S, "Prevalence of vitamin d deficiency and its related factors among university students in Shiraz, Iran" 5 : 796-799, 2014

21 Hovsepian S, "Prevalence of vitamin D deficiency among adult population of Isfahan City, Iran" 29 : 149-155, 2011

22 Raval CM, "Prevalence of premenstrual syndrome and premenstrual dysphoric disorder among college students of Bhavnagar, Gujarat" 58 : 164-170, 2016

23 Babazadeh R, "Premenstrual syndrome and complementary medicine in Iran : a systematic review" 15 : 174-187, 2011

24 Obeidat BA, "Premenstrual symptoms in dysmenorrheic college students : prevalence and relation to vitamin D and parathyroid hormone levels" 9 : 4210-4222, 2012

25 Roozbeh N, "Potential role of Factor V Leiden mutation in adverse pregnancy outcomes : an updated systematic review" 4 : 1832-1846, 2017

26 Bertone-Johnson ER, "Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study" 14 : 56-, 2014

27 Forman JP, "Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans" 55 : 1283-1288, 2010

28 Lo CK, "Newcastle-Ottawa Scale : comparing reviewers’ to authors’ assessments" 14 : 45-, 2014

29 World Health Organization, "National policy on traditional medicine and regulation of herbal medicines: report of a WHO global survey" World Health Organization 2005

30 Thys-Jacobs S, "Micronutrients and the premenstrual syndrome : the case for calcium" 19 : 220-227, 2000

31 Bahrami A, "Menstrual disorders and premenstrual symptoms in adolescents : prevalence and relationship to serum calcium and vitamin D concentrations" 38 : 989-995, 2018

32 Sharma G, "Luteal phase serum calcium and serum magnesium levels in causation of premenstrual syndrome" 4 : 126-130, 2015

33 Ghalwa NA, "Impact of calcium and magnesium dietary changes on women pain and discomfort from premenstrual syndrome at the Faculty of Pharmacy-Gaza strip" 3 : 981-1005, 2014

34 Kaykhaei MA, "High prevalence of vitamin D deficiency in Zahedan, southeast Iran" 58 : 37-41, 2011

35 Bahrami A, "High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents" 34 : 659-663, 2018

36 Cioni F, "Handbook of diet and nutrition in the menstrual cycle, periconception and fertility" Wageningen Academic Publishers 121-136, 2014

37 Holick MF, "Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited" 97 : 1153-1158, 2012

38 American College of Obstetricians and Gynecologists, "Frequently asked questions FAQ057: gynecologic problems:premenstrual syndrome" American College of Obstetricians and Gynecologists 2011

39 Dadkhah H, "Evaluating the effects of vitamin D and vitamin E supplement on premenstrual syndrome : a randomized, double-blind, controlled trial" 21 : 159-164, 2016

40 Akhlaghi F, "Effects of calcium supplementation on premenstrual syndrome" 10 : 669-675, 2004

41 Ghanbari Z, "Effects of calcium supplement therapy in women with premenstrual syndrome" 48 : 124-129, 2009

42 Miyashita M, "Effects of 1, 25-dihydroxy vitamin D3 on endometriosis" 101 : 2371-2379, 2016

43 Khajehei M, "Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome" 105 : 158-161, 2009

44 Kermani AZ, "Effect of combined calcium and vitamin E consumption on premenstrual syndrome" 23 : 8-14, 2010

45 Fatemeh Shobeiri, "Effect of calcium on premenstrual syndrome: A double-blind randomized clinical trial" 대한산부인과학회 60 (60): 100-105, 2017

46 Shobeiri F, "Effect of calcium on physical symptoms of premenstrual syndrome" 19 : 1-8, 2016

47 Samieipour S, "Effect of calcium and vitamin B1 on the severity of premenstrual syndrome : a randomized control trial" 8 : 18706-18717, 2016

48 Hatice Kahyaoglu Sut, "Effect of Premenstrual Syndrome on Work-Related Quality of Life in Turkish Nurses" 한국산업안전보건공단 산업안전보건연구원 7 (7): 78-82, 2016

49 Bertone-Johnson ER, "Dietary vitamin D intake, 25-hydroxyvitamin D3 levels and premenstrual syndrome in a college-aged population" 121 : 434-437, 2010

50 Mortola JF, "Diagnosis of premenstrual syndrome by a simple, prospective, and reliable instrument : the calendar of premenstrual experiences" 76 : 302-307, 1990

51 Bohrer T, "Depression as a manifestation of latent chronic hypoparathyroidism" 8 : 56-59, 2007

52 Harris HR, "Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis : a prospective cohort study" 177 : 420-430, 2013

53 Thys-Jacobs S, "Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder" 92 : 2952-2959, 2007

54 Mandana Z, "Comparison of the effect of vit E, vitB6, calcium and omega-3 on the treatment of premenstrual syndrome : a clinical randomized trial" 4 : 1141-1149, 2014

55 Bharati M, "Comparing the effects of yoga & oral calcium administration in alleviating symptoms of premenstrual syndrome in medical undergraduates" 5 : 179-185, 2016

56 Samieipour S, "Comparing the effects of vitamin B1 and calcium on premenstrual syndrome(PMS)among female students, Ilam-Iran" 4 : 3519-3528, 2016

57 Shehata NA, "Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome : a double blind randomized placebo controlled trial" 198 : 100-104, 2016

58 Pambudi MF, "Calcium level is lower in women with premenstrual syndrome" 37 : 99-102, 2013

59 Bertone-Johnson ER, "Calcium and vitamin D intake and risk of incident premenstrual syndrome" 165 : 1246-1252, 2005

60 Halbreich U, "Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder" 20 : 523-547, 2006

61 Sutariya S, "An interventional study(calcium supplementation & health education)on premenstrual syndrome-effect on premenstrual and menstrual symptoms" 2 : 100-104, 2011

62 Brahmbhatt S, "A prospective survey study on premenstrual syndrome in young and middle aged women with an emphasis on its management" 1 : 69-72, 2013

63 Yonkers KA, "A pilot study to compare fluoxetine, calcium, and placebo in the treatment of premenstrual syndrome" 33 : 614-620, 2013

64 Kim TH, "A comparison in vitamin D receptor expression during oral menopausal hormone therapy and vaginal estrogen therapy" 45 : 39-43, 2018